Streetbeat News

Revenues

CART

Maplebear, known as Instacart, forecasts a Q1 Gross Transaction Value (GTV) growth of 7%-10% and an adjusted EBITDA of $150M-$160M.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 10:10 pm

INCR

InterCure Ltd. (NASDAQ:INCR), a leading medical cannabis company, provided an update on its Nir Oz facility in Southern Israel, affected by the ongoing war situation declared on October 7, 2023. The site has limited access and is partially used by the IDF. Restoration efforts are underway, and the company is seeking full compensation from the Israeli government for damages. InterCure is committed to supporting patient communities and plans to file its preliminary and full financial results for 2023 in early 2024.

Portfolio Pulse from Happy Mohamed

February 13, 2024 | 10:04 pm

SGML

Sigma Lithium (NASDAQ:SGML) has received a letter of intent from the Development Bank of Brazil (BNDES) for additional funding for its Grota do Cirilo lithium project in Brazil. The company plans to invest $100 million in a second processing plant to double its output. The project, which has received full environmental licensing, aims to become the world's fourth-largest lithium mining complex. Despite a recent downturn in lithium prices, Sigma remains optimistic about its strategic position and its focus on sustainable lithium production.

Portfolio Pulse from Stjepan Kalinic

February 13, 2024 | 9:56 pm

TYGO

Tigo Energy forecasts its Q1 2024 revenue to be between $9M and $14M, which is below the estimated $15.067M.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:56 pm

SMWB

Similarweb forecasts Q1 total revenue to be between $58.5M and $59M, surpassing the estimated $57.52M. Additionally, the company projects its FY24 revenue to range from $242M to $246M, exceeding the $239M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:56 pm

MIR

Mirion Technologies forecasts its FY24 adjusted EPS to be between $0.37 and $0.42, compared to the estimated $0.39. The company also expects revenue growth of 5%-7% for the same period.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:54 pm

LRMR

Larimar Therapeutics, Inc. (LRMR) announced a proposed underwritten public offering of its common stock and pre-funded warrants. The offering includes a 30-day option for underwriters to purchase an additional 15% of the securities. The offering's completion, size, and terms are subject to market conditions. Leerink Partners, Citigroup, and Guggenheim Securities are the joint bookrunning managers, with LifeSci Capital as the lead manager. The proceeds are intended for the development of nomlabofusp (CTI-1601), other pipeline candidates, working capital, and general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:54 pm

ENTG

Entegris has provided its Q1 sales and earnings forecast, expecting sales between $770M-$790M, below the estimated $803.42M, and adjusted EPS of $0.60-$0.65, aligning with the estimated $0.64. The company also anticipates an Adjusted EBITDA margin of 26.5% to 27.5%.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:52 pm

GNSS

Genasys anticipates a back-end loaded fiscal year in FY24, with a significant majority of its hardware revenue expected in H2 2024. The company also expects continued growth in software revenue, approaching FY22 levels.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:51 pm

CHCT

Community Healthcare (CHCT) reported Q4 2023 earnings of $0.61 per share, surpassing the $0.58 estimate by 5.17%. However, their quarterly sales of $29.12M fell short of the $29.76M estimate by 2.14%, despite being a 14.92% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 9:51 pm